Radnor, PA – According to filings with the U.S. Securities and Exchange Commission, Nia Therapeutics is raising $8,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Daniel Rizzuto played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Nia Therapeutics
Nia Therapeutics is developing first in class therapeutic devices to restore memory after brain injury and degenerative disease. Our proprietary neurotechnology platform interprets the brain activity related to memory and provides a personalized neurostimulation therapy for each patient. Our Smart Neurostimulation System represents the next generation of direct brain stimulation devices: smart, connected, and powered by artificial intelligence.

To learn more about Nia Therapeutics, visit http://niatherapeutics.com/

Contact:
Daniel Rizzuto, Chief Executive Officer
267-560-7402
dan@niatherapeutics.com
https://www.linkedin.com/in/rizzuto/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved